French biotech startup AbTx has raised €1.7 million to develop miniaturised cancer antibodies using its Therano-Stick platform.
We surfaced this piece through the HealXRlabs lens — published originally on Ventureburn. Continue to the full article on their site.
Looking for our own thinking? Read HealXRlabs Insights →
